Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

PU.1 and Haematopoietic Cell Fate: Dosage Matters.

Mak KS, Funnell AP, Pearson RC, Crossley M.

Int J Cell Biol. 2011;2011:808524. doi: 10.1155/2011/808524. Epub 2011 Aug 10.

2.

PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis.

Gupta P, Gurudutta GU, Saluja D, Tripathi RP.

J Cell Mol Med. 2009 Nov-Dec;13(11-12):4349-63. doi: 10.1111/j.1582-4934.2009.00757.x. Epub 2009 Apr 6. Review.

3.

Is PU.1 a dosage-sensitive regulator of haemopoietic lineage commitment and leukaemogenesis?

Dakic A, Wu L, Nutt SL.

Trends Immunol. 2007 Mar;28(3):108-14. Epub 2007 Jan 30. Review.

PMID:
17267285
4.

Stem cell fate specification: role of master regulatory switch transcription factor PU.1 in differential hematopoiesis.

Gangenahalli GU, Gupta P, Saluja D, Verma YK, Kishore V, Chandra R, Sharma RK, Ravindranath T.

Stem Cells Dev. 2005 Apr;14(2):140-52. Review.

PMID:
15910240
5.

The importance of PU.1 concentration in hematopoietic lineage commitment and maturation.

Dahl R, Simon MC.

Blood Cells Mol Dis. 2003 Sep-Oct;31(2):229-33. Review.

PMID:
12972030
6.

Role of PU.1 in hematopoiesis.

Fisher RC, Scott EW.

Stem Cells. 1998;16(1):25-37. Review.

7.

Analysis of concentration-dependent functions of PU.1 in hematopoiesis using mouse models.

DeKoter RP, Kamath MB, Houston IB.

Blood Cells Mol Dis. 2007 Nov-Dec;39(3):316-20. Epub 2007 Jul 13. Review.

8.

The role of Ets family transcription factor PU.1 in hematopoietic cell differentiation, proliferation and apoptosis.

Oikawa T, Yamada T, Kihara-Negishi F, Yamamoto H, Kondoh N, Hitomi Y, Hashimoto Y.

Cell Death Differ. 1999 Jul;6(7):599-608. Review.

9.

Haematopoietic cell-fate decisions, chromatin regulation and ikaros.

Georgopoulos K.

Nat Rev Immunol. 2002 Mar;2(3):162-74. Review.

PMID:
11913067
10.

Function of PU.1 (Spi-1), C/EBP, and AML1 in early myelopoiesis: regulation of multiple myeloid CSF receptor promoters.

Zhang DE, Hohaus S, Voso MT, Chen HM, Smith LT, Hetherington CJ, Tenen DG.

Curr Top Microbiol Immunol. 1996;211:137-47. Review.

PMID:
8585944
11.

Acute myeloid leukemia: a central role for the ETS factor ERG.

Martens JH.

Int J Biochem Cell Biol. 2011 Oct;43(10):1413-6. doi: 10.1016/j.biocel.2011.05.014. Epub 2011 Jun 1. Review.

PMID:
21664289
12.

From hematopoietic progenitors to B cells: mechanisms of lineage restriction and commitment.

Ramírez J, Lukin K, Hagman J.

Curr Opin Immunol. 2010 Apr;22(2):177-84. doi: 10.1016/j.coi.2010.02.003. Epub 2010 Mar 6. Review.

13.

Mouse models in the study of the Ets family of transcription factors.

Bartel FO, Higuchi T, Spyropoulos DD.

Oncogene. 2000 Dec 18;19(55):6443-54. Review.

14.

PU.1: An ETS family transcription factor that regulates leukemogenesis besides normal hematopoiesis.

Gupta P, Gurudutta GU, Verma YK, Kishore V, Gulati S, Sharma RK, Chandra R, Saluja D.

Stem Cells Dev. 2006 Aug;15(4):609-17. Review.

PMID:
16978063
15.

The transcription factor PU.1 does not regulate lineage commitment but has lineage-specific effects.

McKercher SR, Henkel GW, Maki RA.

J Leukoc Biol. 1999 Nov;66(5):727-32. Review.

PMID:
10577501
16.

Regulation of CSF-1 receptor expression.

Hume DA, Yue X, Ross IL, Favot P, Lichanska A, Ostrowski MC.

Mol Reprod Dev. 1997 Jan;46(1):46-52; discussion 52-3. Review.

PMID:
8981363
17.

Transcription factor interplay during Drosophila haematopoiesis.

Waltzer L, Gobert V, Osman D, Haenlin M.

Int J Dev Biol. 2010;54(6-7):1107-15. doi: 10.1387/ijdb.093054lw. Review.

Supplemental Content

Support Center